We would like to invite you to join us for the symposium “Artificial Intelligence for Prostate Cancer Diagnosis and Screening on MRI: Current Practice, Evidence Gaps, and the Research Agenda” on June 1st (08:30 – 12:30), Theaterzaal C.
For more information and registration, visit https://pi-cai.org/symposium-2026
Artificial intelligence (AI) is rapidly transforming prostate cancer detection on MRI, yet translation into routine clinical practice remains limited. This symposium brings together experts from radiology, urology, epidemiology, and industry to discuss evidence, research priorities, and implementation strategies, including benchmarking and workflow integrations, scaling validation across diverse populations and care settings, and leveraging AI for capacity expansion and population-level screening.
What can you expect?
- Current evidence & gaps — a critical overview of the evidence base and limitations for clinical adoption of prostate AI
- Clinical workflow integration — how AI can be embedded into radiology and urology practice, from decision support to selective automation
- Towards early detection & screening — lessons from breast cancer screening and future prostate cancer strategies
- Multidisciplinary discussion — interactive sessions and panels addressing implementation and the research agenda
In the afternoon, starting from 14:30, Jasper Twilt and Anindo Saha will defend their PhD dissertations on AI for prostate cancer detection on MRI, highlighting key developments from the PI-CAI consortium.
Whether you work in radiology, urology, AI, data science, or any field at the intersection of medicine and technology, this event is for you.
We look forward to welcoming you.
On behalf of the organizing team,
Jasper Twilt and Anindya Shaha
